Quetiapine Tablet, Extended Release
Product Images NDC 33342-137

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 33342-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine-fig-1 (Quetiapine Fig 1)

Chemical structure of quetiapine. The diagram shows the molecular structure of quetiapine, including its heterocyclic components and functional groups, as part of the extended-release formulation.*

FDA Label Image

Quetiapine-fig-2 (Quetiapine Fig 2)

A line graph showing the proportion of patients with relapse (%) over time (months) comparing two groups: PLA and QTF XR. The graph depicts relapse rates increasing more rapidly in the PLA group than in the QTF XR group over a 12-month period.*

FDA Label Image

Quetiapine-fig-3 (Quetiapine Fig 3)

A line graph showing the proportion of patients with relapse over time (weeks). Two lines compare QTP + LIVAL and PLA + LIVAL groups, illustrating differences in relapse rates during the study period up to 80 weeks.*

FDA Label Image

Quetiapine-fig-4 (Quetiapine Fig 4)

A line graph showing the proportion of patients with relapse (%) over time (weeks) up to 100 weeks. Two groups are compared, labeled as 'QTP+LIVAL' and 'PLA+LIVAL,' with 'QTP+LIVAL' showing a higher relapse proportion over time compared to 'PLA+LIVAL.'*

FDA Label Image

505 (Quetiapine Er 150mg 60s)

Label for Quetiapine Extended-Release Tablets, USP 150 mg, an oral tablet by Macleods Pharmaceuticals Limited. The label specifies dispensing instructions, dosage strength, storage conditions, and warns to keep out of reach of children. It includes a count of 60 tablets and identifies Macleods Pharma USA, Inc. as the manufacturer for distribution in the US.*

FDA Label Image

505 (Quetiapine Er 150mg 500s)

Label for Quetiapine Extended-Release Tablets USP 150 mg by Macleods Pharmaceuticals Limited. The label includes dosage form as extended-release tablets, strength of 150 mg, package count of 500 tablets, and manufacturer details for Macleods Pharma USA and Macleods Pharmaceuticals Ltd in India. Storage instructions and warnings are also displayed.*

FDA Label Image

505 (Quetiapine Er 200mg 60s)

Label for Quetiapine Extended-Release Tablets, USP 200 mg by Macleods Pharmaceuticals Limited. The label notes the tablet strength as 200 mg, intended for oral use, with a package containing 60 tablets. It includes storage instructions, a warning to keep out of reach of children, and manufacturer details for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd.*

FDA Label Image

505 (Quetiapine Er 200mg 500s)

The label is for Quetiapine Extended-Release Tablets, USP 200 mg by Macleods Pharmaceuticals Limited. It specifies the tablets contain 200 mg quetiapine, dosage as once daily, and packaging of 500 tablets. Storage instructions and warnings, including to keep out of children's reach, are included. The label references Macleods Pharma USA and manufacturing in India.*

FDA Label Image

505 (Quetiapine Er 300mg 60s)

Label for Quetiapine Extended-Release Tablets, USP 300 mg by Macleods Pharmaceuticals Limited. The label indicates 60 tablets per package, to be taken once daily, with instructions to swallow whole without splitting, crushing, or chewing. Storage conditions and manufacturing details for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd., India, are also shown.*

FDA Label Image

505 (Quetiapine Er 300mg 500s)

Label for Quetiapine Extended-Release Tablets, USP 300 mg by Macleods Pharmaceuticals Limited. The label indicates the product is for once daily oral use, contains 300 mg quetiapine (as quetiapine fumarate), and is packaged as 500 tablets. Storage instructions and warnings are included, along with manufacturer and distributor information.*

FDA Label Image

505 (Quetiapine Er 400mg 60s)

Label for Quetiapine Extended-Release Tablets USP 400 mg, oral tablets in a 60-count package. The label indicates the product is manufactured by Macleods Pharmaceuticals Ltd and Macleods Pharma USA, Inc. It includes dosing instructions stating to swallow whole and not to split or chew, with a usual dosage of once daily. Storage instructions and a warning to keep out of reach of children are also present.*

FDA Label Image

505 (Quetiapine Er 400mg 500s)

Label for Quetiapine Extended-Release Tablets, USP 400 mg by Macleods Pharmaceuticals Limited. The label states it contains 500 tablets and includes instructions for storage between 20° to 25°C with permitted excursions. The product is manufactured for Macleods Pharma USA, Inc., Princeton, NJ, and made by Macleods Pharmaceuticals Ltd., India. It warns to keep out of reach of children and indicates the medication is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.